Figure 1. bes1-D Suppresses bri1 Phenotypes and Is Resistant to the BR-Biosynthesis Inhibitor Brassinazole (BRZ)
crease its kinase activity as judged by both autophosa mutant, bes1 (bri1-EMS-suppressor 1), which not only suppresses bri1 dwarf phenotypes but also displays phorylation and transphosphorylation activities. Overexpression of the wild-type BIN2 gene results in a constitutive BR response phenotypes. We cloned the BES1 gene and found that it encodes a phosphoprotein portion of transgenic plants with similar phenotypes to bin2 mutants, suggesting that the bin2 mutations are with high identity to BZR1 (Wang et al., 2002) . BES1 accumulates in the nucleus in response to BL treatment, hypermorphic. Moreover, while overexpression of BIN2 in a weak bri1 allele enhances bri1 phenotypes, reducbut not to treatments by other hormones. We provide genetic and biochemical evidence that BES1 is a subtion of BIN2 levels in bri1 plants suppresses bri1 phenotypes. These results suggest that BIN2 acts downstream strate for and is negatively regulated by BIN2. In addition, we show that downstream target genes are constifrom BRI1 to negatively regulate the BR signaling pathway (Li and Nam, 2002) . However, at this juncture, there tutively expressed or hyperinduced in the bes1 mutant. The results establish a signaling cascade that begins to is no evidence that BIN2 is regulated by BRI1, nor has BIN2 been connected to other signaling components in connect the BL signal to gene expression changes in the nucleus that alter plant growth and development. the pathway.
A role for essential genes in the BR signaling pathway comes from studies of the Arabidopsis det3 mutant.
Results det3 is a dwarf mutant with a de-etiolated phenotype that is also insensitive to BL applications (Cabrera y bes1-D Displays Constitutive BR Responses To identify signaling components downstream of BRI1, Poch et al., 1993; Szekeres et al., 1996) . DET3 encodes the large C subunit (an assembly subunit) of the vacuolar we screened for suppressors of bri1-119, a weak allele of bri1 that harbors a missense mutation in the 70 amino proton-ATPase (V-ATPase; Schumacher et al., 1999) . In the dark, the hypocotyl elongation defect of det3, a very acid island domain (G644D; Friedrichsen et al., 2000). bri1-119 plants, like other bri1 mutants, are dark green weak allele, is somewhat specific for BRs because the mutant hypocotyls can elongate in response to gravity dwarves with short petioles and round and epinastic leaves ( Figure 1A ). We mutagenized 40,000 homozygous when grown upside down. Thus, it seems likely that BR action utilizes V-ATPase activity to initiate changes in bri1-119 seeds with ethyl methanesulfonate (EMS). Approximately 200,000 M2 seedlings were screened in the cellular environment, such as the uptake of water into the vacuole, to promote BR-induced cell elongation.
white light for mutant plants with suppressed bri1 phenotypes. One suppressor named bes1 (bri1-EMS-supHowever, the V-ATPase appears to act in several signaling pathways, only one of which is the cell elongation pressor 1) was identified in a single pool and showed complete suppression of the bri1 phenotypes (Figure response induced by BRs.
Here, we report the isolation and characterization of 1A). When backcrossed to bri1-119, the resulting plants, At1g65310  1006  2591  1230  4950  Putative xyloglucan endoglucanase  At2g40610  4248  6924  4955  10152  Putative expansin  At2g35710  1301  2403  1601  4535  Putative glycogenin  At1g30690  2127  3859  1863  6766  Phosphatidylinositol/phosphatidylcholine transfer protein  At4g20780  2840  4884  3147  6799  Putative Ca-dependent protein kinase  At4g24230  1657  5377  1845  7427  unknown protein  At4g01950  1218  3490  1373  5385  unknown protein  At4g09890  1603  3467  1655  7409  unknown protein Seedlings were treated with BL or mock treatment (Et, ethanol) and used to prepare RNA for microarray analysis using Affymetrix Arabidopsis Gene Chip. The raw data are presented to indicate gene expression levels.
heterozygous for the bes1 mutation, showed similar but seedlings overexpressing BRI1 (Wang et al., 2002 (Wang et al., , 2001 ; Figure 1D ). In the dark, 1 M BRZ inhibited elongation somewhat weaker bes1 phenotypes ( Figure 1A ). F2 plants segregated bes1-like and bri1 plants in a 3:1 ratio of hypocotyls of wild-type ‫%55ف(‬ inhibition), while bri1-119 was hypersensitive to the inhibitor ‫%57ف(‬ inhibition; (data not shown), demonstrating that bes1 was caused by a monogenic semidominant mutation, and therefore Figure 1E ). bes1-D bri1-119 double mutants displayed insensitivity to BRZ (hypocotyl lengths with and without named bes1-D.
bes1-D bri1-119 double mutants had long and bend-BRZ were not significantly different). Together, these results demonstrate that bes1-D is a BR-pathway coning leaf petioles, curly leaves, and displayed early senescence ( Figures 1A and 1B 
BES1 Encodes a BZR1-like Protein and Is Ubiquitously Expressed
The similar BRZ-resistant phenotypes of bes1-D and bzr1-D seedlings grown in the dark suggested that BES1 ). In this paper, we describe a positive regulator, BES1, that acts downstream of BRI1 and BIN2. We show that the regulation of BES1 protein levels plays a central role in BR signal transduction. BL treatment increases both BES1 levels and its nuclear accumulation. In contrast, BES1 protein levels are negatively regulated by BIN2 kinase. We found that mutant bes1 protein is stabilized and accumulates at high levels in bes1-D. The accumulation of bes1 protein in the mutant to levels even higher than wild-type BES1 after BL induction provides an explanation for why bes1-D suppresses both bri1 and bin2 dwarf phenotypes and exhibits constitutive BR-response phenotypes.
Although bes1-D is a gain-of-function mutation, sev- Figure 4C ). Since BL treatment To test if BIN2 phosphorylates BES1 or mutant bes1 in vitro, the proteins were expressed in E. coli, purified does not change BES1 mRNA levels (data not shown), the hormone treatment appears to stabilize BES1 prowith GST or MBP tags, respectively, and used in an in vitro phosphorylation assay. BIN2 efficiently phosphorytein. Because BIN2 interacts with BES1 and decreases BES1 protein levels ( Figure 5 ; see below) and BIN2 is lated BES1 or mutant bes1 to a greater extent than BIN2 autophosphorylation, consistent with 22 putative BIN2 apparently localized in the cytoplasm (J.L., unpublished data), the regulation of BES1 stability likely takes place in sites in BES1 ( Figure 5D, lanes 1-3) . Moreover, the phosphorylation of BES1 and bes1 by BIN2 was specific since the cytoplasm. In the absence of BRs, newly synthesized cytoplasmic BES1 does not accumulate due to the acthe BRI1 kinase did not phosphorylate these proteins ( Figure 5D, lanes 4-6) . tion of BIN2. In the presence of BRs, BES1 is stabilized, allowing it to accumulate and translocate to the nucleus. To confirm that BIN2 phosphorylated BES1 in vivo, we crossed a BES1::GFP transgenic line to bin2-D and BES1 accumulation in the nucleus appears to activate BR target gene expression as indicated by the upregulaassayed BL-induced BES1 dephosphorylation ( Figure  5E ). While the accumulation of unphosphorylated BES1 tion of BL-induced genes in the bes1-D mutant (Table  1) 
